We are delighted to welcome Dr Tom Newsom-Davis as the new chair of the BTOG Steering Committee.
Tom is a consultant thoracic medical oncologist at Chelsea and Westminster Hospital, London. He has an active clinical trials portfolio. He has been UK Chief Investigator for a number of studies, as well as chairing Independent Data Monitoring Committees and sitting on trial steering groups. He has published over 70 papers and presented more than 120 abstracts in national and international meetings.
Tom joined the steering committee of BTOG in 2017. He serves on the Multidisciplinary Clinical Science Committee of the International Association for the Study of Lung Cancer (IASLC), on the Oncology Council of the Royal Society of Medicine, and as an invited clinic expert for NICE. Tom is past Chair of the RM Partners Cancer Alliance Lung group, and past member of the NCRI Lung Cancer Clinical Studies Group.
Tom has been an invited lecturer for various organisations including the Royal College of Physicians, European Society of Medical Oncology (ESMO), IASLC, British Medical Association and the Association of Cancer Physicians. He has been a faculty member for ESMO and IASLC meeting. His work on Acute Diagnostic Oncology Clinics has previously been awarded a Macmillan Innovation Excellence Award.
Tom said: “It is the greatest honour to be appointed Chair of the Steering Committee. I look forward to working with committee colleagues, and the BTOG executive, to continue the fantastic work that BTOG has already done to improve lung cancer care in the UK.”
